1. Molecular Targets in Human Neuroendocrine Tumors
   Ujalla Sheikh et al, 2016, Neuroendocrine Tumors: Review of Pathology, Molecular and Therapeutic Advances CrossRef
2. Clinicopathological and prognostic value of NADPH oxidase 2 (NOX2) in primary osteosarcoma
   Rong-jin Lin et al, 2021, Journal of Orthopaedic Science CrossRef
3. Analysis of polymorphisms in EGF, EGFR and HER2 genes in pancreatic neuroendocrine tumors (PNETs)
   Sonja Marinović et al, 2022, Cancer Genetics CrossRef
4. Recent Advances in Molecular Pathology of Neuroendocrine Neoplasms
   Aejaz Nasir et al, 2016, Neuroendocrine Tumors: Review of Pathology, Molecular and Therapeutic Advances CrossRef
5. The Role of Tumor-Associated Antigen HER2/neu in Tumor Development and the Different Approaches for Using It in Treatment: Many Choices and Future Directions
   Saleh Alrhmoun et al, 2022, Cancers CrossRef
6. Neuroendocrine tumor disease: an evolving landscape
   Andrea Frilling et al, 2012, Endocrine-Related Cancer CrossRef
7. NLRP3 Overexpression Associated With Poor Prognosis and Presented as an Effective Therapeutic Target in Osteosarcoma
   Zhen Huang et al, 2021, Frontiers in Pharmacology CrossRef
8. Prognostic significance of the expression of HER family members in primary osteosarcoma
   Sheng‑Lin Wang et al, 2018, Oncology Letters CrossRef
9. Epidermal Growth Factor Receptor: Key to Selective Intracellular Delivery
   A. A. Rosenkranz et al, 2020, Biochemistry (Moscow) CrossRef
10. Inhibition of BUB1 suppresses tumorigenesis of osteosarcoma via blocking of PI3K/Akt and ERK pathways
    Zhen Huang et al, 2021, Journal of Cellular and Molecular Medicine CrossRef